Moving Trials Forward: Inside the Merck and WCG Partnership that Unblocks Bottlenecks and Empowers Sites

Session details:

Merck redesigned how it works with sites, adopting a relationship-first approach centered on trust, transparency, and consistent communication. The shift was driven by the need to keep increasingly complex studies moving while addressing the operational bottlenecks and day-to-day challenges that can create additional burden for sites. Through more targeted site support, the model focuses on addressing challenges across enrollment, data entry, records management, and study workflows while balancing global consistency with local needs. Key Topics:

• How Merck evolved its sponsor-site engagement model to manage increasing trial complexity
• How targeted site support can identify and resolve operational bottlenecks
• Why transparency helps align sponsors, CROs, and sites around shared accountability
• Lessons from scaling a consistent approach across global markets
• Practical strategies sponsors and CROs can apply to improve site experience and study momentum